Actively Recruiting
Effect of Lipikar Urea 30% Before Actinic Keratoses Treatment
Led by Cosmetique Active International · Updated on 2024-06-18
100
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is conducted in one center in Germany, in adult subjects having actinic keratoses (grade I or II) lesions on the scalp and meeting specific inclusion/exclusion criteria. The purpose of the study is to evaluate a holistic management (efficacy, tolerability and lesion cosmetic outcomes) of Tolak® treatment.
CONDITIONS
Official Title
Effect of Lipikar Urea 30% Before Actinic Keratoses Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of at least 4 non-hypertrophic, non-hyperkeratotic actinic keratosis lesions on the scalp
- Planned treatment of actinic keratoses on the scalp with Tolak4
- Olsen grade I or II actinic keratosis lesions
You will not qualify if you...
- Known or documented intolerance to any ingredients of Tolak4 or Lipikar Urea 30%
- Treatment of actinic keratoses in the treatment area within the past 3 months (e.g., photodynamic therapy, topical 5-FU, diclofenac, imiquimod, cryotherapy)
- Suspected invasive squamous cell cancer in the treatment area
- Chronic wounds, erosions, or inflamed/infected skin disrupting the epidermal barrier in the treatment area currently or within the last 8 weeks
- Given systemic cancer medication or systemic treatment with 5-Fluorouracil
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CentroDerm GmbH
Wuppertal, Germany
Actively Recruiting
Research Team
T
Thomas Dirschka
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here